Department of Internal and Vascular Medicine, Amsterdam UMC, University of Amsterdam, Cardiovascular Sciences, Amsterdam, the Netherlands; Department of Public Health, Amsterdam UMC, University of Amsterdam, Amsterdam Public Health Research Institute, Amsterdam, the Netherlands; Department of Respiratory Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands; Department of Physiology, University of Ghana Medical School, Ghana.
Department of Medicine and Therapeutics, University of Ghana Medical School, Ghana.
Microvasc Res. 2021 Jul;136:104162. doi: 10.1016/j.mvr.2021.104162. Epub 2021 Mar 9.
Although the associations between measures of macrovascular and microvascular dysfunctions are well characterized in diabetes, there is limited data on these associations in individuals without diabetes. We compared the associations between macrovascular dysfunction and renal microvascular dysfunction in individuals with type 2 diabetes (T2D) and without diabetes.
Cross-sectional analyses of baseline data from the multiethnic Healthy Life in an Urban Setting (HELIUS) study (Amsterdam, the Netherlands), including 986 participants with T2D and 7680 participants without diabetes were done. Logistic regression analyses were used to examine the associations between macrovascular dysfunction [aortic stiffness, coronary artery disease (CAD), peripheral artery disease (PAD), and stroke] and renal microvascular dysfunction [albuminuria] with adjustments for age, sex, ethnicity, waist-to-hip ratio, systolic blood pressure, LDL-cholesterol, and smoking (and HbA1c and diabetes duration for the T2D group).
In the fully adjusted models, aortic stiffness was associated with albuminuria in individuals with T2D [OR 2.55; 95% CI,1.30-4.98], but not without diabetes [0.96; 0.63-1.45]; stroke was associated with albuminuria in T2D [2.40;1.10-5.25], but not in non-diabetes [1.39;0.83-2.33]. In age-sex adjusted models, CAD was associated with albuminuria in T2D [1.65;1.09-2.50] and in non-diabetes [1.56;1.13-2.15]; the associations were no longer significant in the fully adjusted model. There were no associations between PAD and albuminuria in T2D and non-diabetes.
Our study shows important differences in the associations between measures of macrovascular and renal microvascular dysfunction in T2D and non-diabetes. These findings provide opportunities for future research aimed at prevention and treatment strategies for individuals with vascular dysfunction.
尽管大血管和微血管功能障碍的测量值在糖尿病患者中具有良好的相关性,但在非糖尿病患者中,关于这些相关性的数据有限。我们比较了 2 型糖尿病(T2D)和非糖尿病患者中大血管功能障碍与肾脏微血管功能障碍之间的相关性。
对多民族健康生活在城市环境(HELIUS)研究(荷兰阿姆斯特丹)的基线数据进行横断面分析,包括 986 名 T2D 患者和 7680 名非糖尿病患者。使用逻辑回归分析来检验大血管功能障碍(主动脉僵硬、冠状动脉疾病 [CAD]、外周动脉疾病 [PAD] 和中风)与肾脏微血管功能障碍(蛋白尿)之间的关联,调整因素包括年龄、性别、种族、腰臀比、收缩压、低密度脂蛋白胆固醇和吸烟(以及 T2D 组的糖化血红蛋白和糖尿病病程)。
在完全调整的模型中,主动脉僵硬与 T2D 患者的蛋白尿相关(OR 2.55;95%CI,1.30-4.98),但与非糖尿病患者无关(0.96;0.63-1.45);中风与 T2D 患者的蛋白尿相关(2.40;1.10-5.25),但与非糖尿病患者无关(1.39;0.83-2.33)。在年龄-性别调整模型中,CAD 与 T2D 患者的蛋白尿相关(1.65;1.09-2.50)和非糖尿病患者的蛋白尿相关(1.56;1.13-2.15);在完全调整的模型中,这些关联不再显著。PAD 与 T2D 和非糖尿病患者的蛋白尿之间无关联。
我们的研究表明,T2D 和非糖尿病患者中大血管和肾脏微血管功能障碍测量值之间的关联存在重要差异。这些发现为针对血管功能障碍患者的预防和治疗策略的未来研究提供了机会。